STARTING PATIENTS ON EVERSENSE CGM just got easier Eversense Bridge Program
Eversense USA   Eversense OUS
STARTING PATIENTS ON EVERSENSE CGM just got easier Eversense Bridge Program
Home
Home

Patient Website

Eversense USA   Eversense OUS
Paragraphs
Inner Content
 

Why Eversense CGM?

 
sensor

90 days

The FDA-approved long-term CGM that lasts up to 90 days.

The advanced sensor technology and under-the-skin sensor help patients reach unprecedented levels of wear time, leading to improved clinical outcomes.

 

The only CGM with a powerful

23.4 HOURS A DAY
WEAR TIME1,2

 
Learn More
Selector Id
why-eversense-cgm
Selector Class
why-eversense-cgm

Eversense

Up to 90-day sensor life

4 sensor changes per year

Only 4 ‘Day 1' warm-up periods

Sensor placement by HCP

Sensor reads glucose values even without transmitter

Sensor stays put no matter what

No irritation from silicone-based transmitter adhesive1

Traditional CGMs

Short sensor life of 7-14 days

26-52 sensor changes per year

26 - 52 ‘Day 1’ warm-up periods

Need to self-insert the sensor

Transmitter must remain adhered to skin for sensor duration

Percutaneous sensor can be dislodged during normal activities

Acrylate-based adhesives can cause irritation

 

How we outpace other CGMS

 
Selector Id
eversense-cgm-system-comp
Selector Class
eversense-cgm-system-comp bg-center-center-tab bg-center-center-mobile
Become a provider
doctor patient
 

Become a provider

 
1

Register for training

2

Begin learning

3

Receive support

4

Start treating patients

Learn More
Selector Class
become-a-provider
Content

“

Freedom, flexibility and empowerment.

Dr. David Ahn, Eversense CGM provider

Watch Dr. Ahn testimonial
Selector Id
user-comment-section
Selector Class
user-comment-section
EVERSENSE® BRIDGE —A NEW PATIENT ACCESS PROGRAM IS HERE!

EVERSENSE® BRIDGE —A NEW PATIENT
ACCESS PROGRAM IS HERE!

Now you can try the Eversense® 90-day CGM System for just $99.*
* For a limited time, patients who meet the Program’s Eligibility Requirements may receive monetary assistance up to a Program maximum towards acquiring the Eversense CGM System (after making an initial $99 payment). The Bridge Program does not apply to sensor placement procedure fees from your healthcare provider, however, and patients must discuss coverage and payment for sensor placement separately with their physician (or other health care provider). Rules and restrictions apply.
Bridge Program
Selector Id
try-eversense
Selector Class
try-eversense
  1. Christiansen MP, Klaff LJ, Brazg R, et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technology & Therapeutics. 2018;20(3):197-206. doi:10.1089/dia.2017.0142.
  2. Christiansen MP, Klaff LJ, Bailey TS, Brazg R, Carlson G, Tweden KS. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study. Diabetes Technology & Therapeutics. 2019;21(5):231-237. doi:10.1089/dia.2019.0020.
Selector Class
section-lists
x